WEDNESDAY, Sept. 19, 2018 — Rivaroxaban does not lower risk of symptomatic venous thromboembolism and related death in medical patients after hospital discharge, compared to placebo, according to a study published in the Sept. 20 issue of the New England Journal of Medicine. Alex C. Spyropoulos, M.D., from Northwell Health at Lenox Hill Hospital in […]